Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

An investigation on the relevance of prolactin, insulin‐like growth factor‐1 and 25‐hydroxyvitamin D3 (25‐OHD3) in canine benign prostatic hyperplasia in a predisposed breed model

Source: Article title. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

An investigation on the relevance of prolactin, insulin‐like growth factor‐1 and 25‐hydroxyvitamin D3 (25‐OHD3) in canine benign prostatic hyperplasia in a predisposed breed model

Study design awaiting verification · Veterinary Medicine and Science · 2021

Original publication title

An investigation on the relevance of prolactin, insulin‐like growth factor‐1 and 25‐hydroxyvitamin D3 (25‐OHD3) in canine benign prostatic hyperplasia in a predisposed breed model

Franziska Werhahn Beining; Marion Schmicke; Mirja Wilkens; Karola Wolf; Karl Rohn; Anne‐Rose Günzel‐Apel

© 2021 The Authors Veterinary Medicine and Science Published by John Wiley & Sons Ltd

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Abstract

Serum concentrations of prolactin (PRL), insulin‐like growth factor‐1 (IGF‐1) and 25 hydroxyvitamin D3 (25‐OHD3) were analysed to investigate their possible involvement in the pathogenesis of benign prostatic hyperplasia (BPH). For this, dogs of the Rhodesian Ridgeback (RR) breed were used because of a verified breed disposition for the development of BPH. Labrador Retrievers (LR) served as controls. The prostate gland status was characterised by the prostate gland volume, clinical signs of BPH (haemospermia and sonographic findings) and the plasma concentration of canine prostate‐specific arginine esterase (CPSE).

Breed specificity in the RR was expressed by a correlation of PRL with breed (p < 0.05). Similar relationships existed in the dogs with normal CPSE (CPSEn) with respect to the IGF‐1 concentrations (LR: p < 0.05). The latter were negatively correlated with prostatic volume and age (both p < 0.05). Concentrations of 25‐OHD3 were tendentially (p = 0.18) lower in the RR with increased CPSE (CPSEi) compared with the CPSEn LR and RR showing clinical signs of BPH.

A negative correlation between serum 25‐OHD3 and age (p < 0.05) existed in the CPSEi RR. Proof of 25‐OHD3 in prostatic secretion proved to be a breed specific feature in the RR (p < 0.0001). For all RR dogs showing clinical signs of BPH, a close to significant (p = 0.06) positive correlation with prostate gland volume was found. The results of the present study reveal no clear hints towards the significance of PRL and IGF‐1 in the pathogenesis of canine BPH.

In the RR breed there were indications of a causal relationship with age‐dependent changes in the vitamin D metabolism. The data suggest the possibility of preventing or treating canine BPH by administering vitamin D or substances involved in the intraprostatic vitamin D metabolism.

Authors’ abstract

Abstract

Serum concentrations of prolactin (PRL), insulin‐like growth factor‐1 (IGF‐1) and 25 hydroxyvitamin D3 (25‐OHD3) were analysed to investigate their possible involvement in the pathogenesis of benign prostatic hyperplasia (BPH). For this, dogs of the Rhodesian Ridgeback (RR) breed were used because of a verified breed disposition for the development of BPH. Labrador Retrievers (LR) served as controls. The prostate gland status was characterised by the prostate gland volume, clinical signs of BPH (haemospermia and sonographic findings) and the plasma concentration of canine prostate‐specific arginine esterase (CPSE).

Breed specificity in the RR was expressed by a correlation of PRL with breed (p < 0.05). Similar relationships existed in the dogs with normal CPSE (CPSEn) with respect to the IGF‐1 concentrations (LR: p < 0.05). The latter were negatively correlated with prostatic volume and age (both p < 0.05). Concentrations of 25‐OHD3 were tendentially (p = 0.18) lower in the RR with increased CPSE (CPSEi) compared with the CPSEn LR and RR showing clinical signs of BPH.

A negative correlation between serum 25‐OHD3 and age (p < 0.05) existed in the CPSEi RR. Proof of 25‐OHD3 in prostatic secretion proved to be a breed specific feature in the RR (p < 0.0001). For all RR dogs showing clinical signs of BPH, a close to significant (p = 0.06) positive correlation with prostate gland volume was found. The results of the present study reveal no clear hints towards the significance of PRL and IGF‐1 in the pathogenesis of canine BPH.

In the RR breed there were indications of a causal relationship with age‐dependent changes in the vitamin D metabolism. The data suggest the possibility of preventing or treating canine BPH by administering vitamin D or substances involved in the intraprostatic vitamin D metabolism.

Publication and source details

Original title: An investigation on the relevance of prolactin, insulin‐like growth factor‐1 and 25‐hydroxyvitamin D3 (25‐OHD3) in canine benign prostatic hyperplasia in a predisposed breed model

Franziska Werhahn Beining; Marion Schmicke; Mirja Wilkens; Karola Wolf; Karl Rohn; Anne‐Rose Günzel‐Apel

Veterinary Medicine and Science · 2021

* Correspondence
Anne‐Rose Günzel‐Apel, Unit of Reproductive Medicine: Small Animal Clinic, University of Veterinary Medicine Hannover, Hannover, Germany.
Email: anne-rose.guenzel-apel@tiho-hannover.de
© 2021 The Authors Veterinary Medicine and Science Published by John Wiley & Sons Ltdhttps://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.Stiftung Tierärztliche Hochschule Hannover 10.13039/501100005629

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T12:46:26.654971+00:00

DOI: 10.1002/vms3.514 · PMC8464227